- Report
- February 2026
- 171 Pages
Global
From €5102EUR$5,850USD£4,425GBP
- Report
- February 2026
- 282 Pages
Global
From €5102EUR$5,850USD£4,425GBP
- Report
- February 2026
- 274 Pages
Global
From €5102EUR$5,850USD£4,425GBP
- Report
- February 2026
- 193 Pages
Global
From €5102EUR$5,850USD£4,425GBP
- Report
- September 2025
- 250 Pages
Global
From €3916EUR$4,490USD£3,396GBP
- Report
- September 2025
- 250 Pages
Global
From €3916EUR$4,490USD£3,396GBP
- Report
- August 2025
- 250 Pages
Global
From €3916EUR$4,490USD£3,396GBP
- Report
- April 2025
- 175 Pages
Global
From €3916EUR$4,490USD£3,396GBP
- Report
- March 2025
- 250 Pages
Global
From €3916EUR$4,490USD£3,396GBP
- Report
- January 2026
- 180 Pages
Global
From €3925EUR$4,500USD£3,404GBP
- Report
- January 2026
- 185 Pages
Global
From €3925EUR$4,500USD£3,404GBP
- Report
- January 2026
- 182 Pages
Global
From €3925EUR$4,500USD£3,404GBP
- Report
- September 2025
- 150 Pages
Global
From €3488EUR$3,999USD£3,025GBP
- Report
- April 2025
- 144 Pages
Global
From €3488EUR$3,999USD£3,025GBP
- Report
- July 2025
- 350 Pages
Global
From €4316EUR$4,949USD£3,743GBP
- Report
- September 2025
- 150 Pages
Global
From €3358EUR$3,850USD£2,912GBP
€4230EUR$4,850USD£3,668GBP
- Report
- August 2025
- 150 Pages
Global
From €3358EUR$3,850USD£2,912GBP
€4230EUR$4,850USD£3,668GBP
- Report
- March 2025
- 150 Pages
Global
From €3358EUR$3,850USD£2,912GBP
€4230EUR$4,850USD£3,668GBP
- Report
- March 2025
- 150 Pages
Global
From €3358EUR$3,850USD£2,912GBP
€4230EUR$4,850USD£3,668GBP
- Report
- August 2025
- 271 Pages
Global
From €4356EUR$4,995USD£3,778GBP

The Therapeutic Vaccine market is a subset of the Vaccines market, focusing on the development of vaccines to treat existing diseases. These vaccines are designed to stimulate the body's immune system to fight off existing infections, rather than prevent them. Therapeutic Vaccines are used to treat a variety of diseases, including cancer, HIV, and hepatitis. They are also used to treat autoimmune diseases, such as multiple sclerosis and rheumatoid arthritis.
Therapeutic Vaccines are typically administered in a series of doses, and may require additional booster shots to maintain their effectiveness. They are often used in combination with other treatments, such as chemotherapy or radiation therapy.
Companies in the Therapeutic Vaccine market include Merck, GlaxoSmithKline, Sanofi, Pfizer, and Johnson & Johnson. Other companies, such as Moderna and Novavax, are also developing therapeutic vaccines. Show Less Read more